Oriola Oyj (LON:0NES)
London
· Delayed Price · Currency is GBP · Price in EUR 1.088
+0.007 (0.65%)
At close: Apr 28, 2025
Oriola Oyj Revenue
In the year 2024, Oriola Oyj had annual revenue of 1.68B EUR with 12.45% growth. Oriola Oyj had revenue of 442.20M in the quarter ending December 31, 2024, with 14.03% growth.
Revenue
1.68B EUR
Revenue Growth
+12.45%
P/S Ratio
0.12
Revenue / Employee
1.80M EUR
Employees
934
Market Cap
168.35M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.68B | 186.10M | 12.45% |
| Dec 31, 2023 | 1.50B | -44.60M | -2.90% |
| Dec 31, 2022 | 1.54B | 87.50M | 6.03% |
| Dec 31, 2021 | 1.45B | -348.70M | -19.36% |
| Dec 31, 2020 | 1.80B | 79.30M | 4.61% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |